AR047763A1 - Extracto de carne y peptonas, separados o en combinacion, para reestablecer la integridad del intestino - Google Patents

Extracto de carne y peptonas, separados o en combinacion, para reestablecer la integridad del intestino

Info

Publication number
AR047763A1
AR047763A1 ARP040103711A ARP040103711A AR047763A1 AR 047763 A1 AR047763 A1 AR 047763A1 AR P040103711 A ARP040103711 A AR P040103711A AR P040103711 A ARP040103711 A AR P040103711A AR 047763 A1 AR047763 A1 AR 047763A1
Authority
AR
Argentina
Prior art keywords
intestine
integrity
combination
meat
extract
Prior art date
Application number
ARP040103711A
Other languages
English (en)
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34354433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR047763(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of AR047763A1 publication Critical patent/AR047763A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

El uso de peptonas y extracto de carne, en forma separada o en combinacion, en la fabricacion de una composicion oral para tratar los efectos de la infeccion por bacterias patogena tal como Clostridium difficile. Tales efectos pueden incluir la falla de la integridad de las células epiteliales del intestino y la diarrea así como otros efectos mediados por el COX-2.
ARP040103711A 2003-10-13 2004-10-13 Extracto de carne y peptonas, separados o en combinacion, para reestablecer la integridad del intestino AR047763A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03023016 2003-10-13

Publications (1)

Publication Number Publication Date
AR047763A1 true AR047763A1 (es) 2006-02-22

Family

ID=34354433

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040103711A AR047763A1 (es) 2003-10-13 2004-10-13 Extracto de carne y peptonas, separados o en combinacion, para reestablecer la integridad del intestino

Country Status (17)

Country Link
US (1) US8216605B2 (es)
EP (1) EP1675601B2 (es)
JP (1) JP4918361B2 (es)
CN (2) CN1886144A (es)
AR (1) AR047763A1 (es)
AT (1) ATE435022T1 (es)
BR (1) BRPI0415385A (es)
CA (1) CA2542448A1 (es)
DE (1) DE602004021831D1 (es)
DK (1) DK1675601T4 (es)
ES (1) ES2328149T5 (es)
IL (1) IL174978A0 (es)
MY (1) MY140220A (es)
PT (1) PT1675601E (es)
TW (1) TW200520696A (es)
WO (1) WO2005039606A2 (es)
ZA (1) ZA200603824B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0415388A (pt) * 2003-10-13 2006-12-12 Nestec Sa moderação do efeito das endotoxinas
CN113729228A (zh) * 2020-05-29 2021-12-03 安琪纽特股份有限公司 用于预防或改善腹泻的组合物及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US177534A (en) * 1876-05-16 Improvement in meat-extracts
US4595590A (en) * 1984-01-17 1986-06-17 Laboratoires Biocodex Method for preventing or treating pseudo-membranous colitis
JPS61236727A (ja) * 1985-04-12 1986-10-22 Advance Res & Dev Co Ltd 抗う蝕乃至抗菌周症剤
JP2805490B2 (ja) † 1989-02-07 1998-09-30 雪印乳業株式会社 細菌毒素中和剤
CN1056750C (zh) * 1993-12-10 2000-09-27 济南三株药业有限公司 一种营养保健口服液及其制法
US5550106A (en) * 1994-03-04 1996-08-27 Bristol-Myers Squibb Company Low buffer nutritional composition
RU2168915C2 (ru) * 1996-03-19 2001-06-20 Алтайский научно-исследовательский проектно-технологический институт животноводства Мясной продукт для детского питания
US7374753B1 (en) * 1997-06-03 2008-05-20 Ganeden Biotech, Inc. Probiotic lactic acid bacterium to treat bacterial infections associated with SIDS
US6368591B2 (en) * 1998-05-15 2002-04-09 Shanghai Sine Pharmaceutical Corporation Ltd. Beneficial microbe composition, new protective materials for the microbes, method to prepare the same and uses thereof
JP2001008636A (ja) * 1999-06-30 2001-01-16 Tanabe Seiyaku Co Ltd 感染症防止用飼料組成物
JP2001055338A (ja) * 1999-08-13 2001-02-27 Kirin Brewery Co Ltd 酵母細胞壁画分からなる薬理用組成物
JP3307627B2 (ja) * 2000-02-09 2002-07-24 オク タイン 酵母ジゴサッカロマイシスロキシイ（Ｚｙｇｏｓａｃｃｈａｒｏｍｙｃｅｓｒｏｕｘｉｉ）からサイトカラシン（Ｃｙｔｏｃｈａｌａｓｉｎ）様物質群を製造する方法。
NL1014380C2 (nl) * 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
JP2002080351A (ja) * 2000-09-07 2002-03-19 Natl Fedelation Of Agricult Coop Assoc 免疫増強剤
SE0003958D0 (sv) * 2000-10-31 2000-10-31 Biogaia Fermentation Ab Method for growth of microorganisms
FI114895B (fi) * 2001-05-14 2005-01-31 Suomen Rehu Oy Ravinnon lisäaine
JP2005504017A (ja) † 2001-06-29 2005-02-10 バイオティ セラピィーズ コープ 少なくとも１種の糖含有阻害性物質の用途
WO2004003235A2 (en) * 2002-06-28 2004-01-08 Puleva Biotech, S.A. Probiotic strains, a process for the selection of them, compositions thereof, and their use
EP1531832B1 (en) † 2002-06-28 2009-04-15 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
ES2268432T3 (es) * 2002-07-23 2007-03-16 Wm. Wrigley Jr. Company Sabores encapsulados y goma de mascar que emplea los mismos.
BRPI0415388A (pt) † 2003-10-13 2006-12-12 Nestec Sa moderação do efeito das endotoxinas

Also Published As

Publication number Publication date
CA2542448A1 (en) 2005-05-06
WO2005039606A3 (en) 2005-09-15
PT1675601E (pt) 2009-08-31
US20070122453A1 (en) 2007-05-31
DK1675601T3 (da) 2009-11-09
DE602004021831D1 (de) 2009-08-13
EP1675601A2 (en) 2006-07-05
EP1675601B2 (en) 2013-04-10
CN102319417A (zh) 2012-01-18
IL174978A0 (en) 2006-08-20
MY140220A (en) 2009-12-31
ATE435022T1 (de) 2009-07-15
EP1675601B1 (en) 2009-07-01
ZA200603824B (en) 2007-07-25
ES2328149T3 (es) 2009-11-10
DK1675601T4 (da) 2013-05-06
JP2007527410A (ja) 2007-09-27
TW200520696A (en) 2005-07-01
CN102319417B (zh) 2014-08-13
BRPI0415385A (pt) 2006-12-12
CN1886144A (zh) 2006-12-27
JP4918361B2 (ja) 2012-04-18
US8216605B2 (en) 2012-07-10
WO2005039606A2 (en) 2005-05-06
ES2328149T5 (es) 2013-07-12

Similar Documents

Publication Publication Date Title
AR106800A1 (es) Composiciones que comprenden cepas bacterianas
CO2020009670A2 (es) Composiciones que comprenden microbiota coseleccionada y métodos para su uso
CL2008003406A1 (es) Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih.
ECSP20084434A (es) Tiofenocarboxamidas sustituidas y análogos como agentes antibacterianos
CL2011000729A1 (es) Compuestos derivados de metanopirazolo[3,4-e][1,3]diazepin; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
CL2012001950A1 (es) Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
MX2018005971A (es) Composicion farmaceutica novedosa que comprende particulas que comprenden un complejo de un polirribonucleotido de hebra doble y una polialquilenimina.
CL2011002548A1 (es) Compuestos derivados de resolviina; composicion farmaceutica; uso de la composicion; kit farmaceutico; combinacion farmaceutica; uso de los compuestos en el tratamiento y/o prevencion de una condicion oftalmica.
GT201400043A (es) Imidazopiridazinas sustituidas con amino
MX2017015674A (es) Suplemento dietetico.
AR033574A1 (es) Una cepa bacteriana del grupo de las bacterias lacticas capaces de reducir la tendencia de un individuo a desarrollar reacciones alergicas, las composiciones alimenticias y farmaceuticas que la contienen y las vacunas que la contienen
AR069943A1 (es) Metodo para reducir la circunferencia abdominal mediante la administracion de una bacteria bifidobacterium
CR20210682A (es) Antibióticos macrocíclicos de amplio espectro
CO2019010001A2 (es) Antibióticos macrociclicos de amplio espectro
MX387476B (es) Antibióticos de amplio espectro macrocíclico.
AR071125A1 (es) Peptidos muy puenteados a partir de actinomadura namibiensis
UY30042A1 (es) Nuevos derivados de alquilfosfolípidos con citotoxicidad reducida y usos de los mismos.
AR047763A1 (es) Extracto de carne y peptonas, separados o en combinacion, para reestablecer la integridad del intestino
MX2018007158A (es) Uso de compuestos fenolicos derivados de arandano como agente sinergizante antibiotico contra bacterias patogenicas.
AR072426A1 (es) Uso de nifurtimox para el tratamiento de enfermedades causadas por tricomonadida
CL2008001613A1 (es) Compuestos macrociclicos; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
MX2021010671A (es) Sistema de expresion procariota inducible por cloruro.
AR046107A1 (es) Uso de extractos de levadura para restaurar la integridad del intestino
PA8651401A1 (es) Formas de dosificacion oral solidas que contienen una dosis baja de estradiol

Legal Events

Date Code Title Description
FA Abandonment or withdrawal